The Annals Take our Readership Survey!
home help contact us subscription past issues search current issue
 QUICK SEARCH:   [advanced]


     



Published Online, 14 October 2005, www.theannals.com, DOI 10.1345/aph.1G280.
The Annals of Pharmacotherapy: Vol. 39, No. 12, pp. 2009-2014. DOI 10.1345/aph.1G280
© 2005 Harvey Whitney Books Company.
This Article
Right arrow Full Text
Right arrow PDF
Right arrow For Our Patients
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Articles Ahead of Print
Right arrow [Order Reprint]
Citing Articles
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Fillenbaum, G. G
Right arrow Articles by Gray, S. L
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Fillenbaum, G. G
Right arrow Articles by Gray, S. L

ALZHEIMER'S DISEASE

Dementia and Alzheimer's Disease in Community-Dwelling Elders Taking Vitamin C and/or Vitamin E

Gerda G Fillenbaum, PhD1, Maragatha N Kuchibhatla, PhD2, Joseph T Hanlon, PharmD3, Margaret B Artz, PhD4, Carl F Pieper, DrPH5, Kenneth E Schmader, MD6, Maurice W Dysken, MD7, and Shelly L Gray, PharmD MS BCPS8

1 Research Professor of Medical Psychology and Research Professor in Nursing, Duke University Medical Center and Geriatric Research, Education and Clinical Center, Veterans Affairs Medical Center, Durham, NC; Center for the Study of Aging and Human Development, Duke University Medical Center, Durham
2 Assistant Research Professor, Department of Biostatistics and Bioinformatics, Duke University Medical Center; Center for the Study of Aging and Human Development, Duke University Medical Center
3 Visiting Professor, University of Pittsburgh and Center for Health Equity and Promotion, Veterans Affairs Pittsburgh Health Care Center, Pittsburgh, PA; Department of Medicine (Geriatrics), University of Pittsburgh
4 Assistant Professor, Department of Pharmaceutical Care and Health Systems, College of Pharmacy, University of Minnesota, Minneapolis, MN
5 Assistant Research Professor, Department of Biostatistics and Bioinformatics, Duke University Medical Center; Center for the Study of Aging and Human Development, Duke University Medical Center
6 Associate Professor, Duke University Medical Center and Geriatric Research, Education and Clinical Center, Veterans Affairs Medical Center, Durham; Department of Medicine, Division of Geriatrics, Duke University Medical Center
7 Professor, University of Minnesota and Director, Geriatric Research, Education, and Clinical Center Program, Minneapolis Veterans Affairs Medical Center, Minneapolis
8 Associate Professor, Geriatric Pharmacy Program, School of Pharmacy, University of Washington, Seattle, WA

Reprints: Dr. Fillenbaum, Center for the Study of Aging and Human Development, Duke University Medical Center, Box 3003, Durham, NC 27710-3003, fax 919/684-8569, ggf{at}geri.duke.edu

BACKGROUND: Since increased oxidative stress may impair cognition and be a risk factor for dementia, there has been interest in determining whether use of antioxidants could protect against such events.

OBJECTIVE: To determine whether supplement use of vitamins C and/or E in a community-based sample of older African American and white individuals delayed incident dementia or Alzheimer's disease (AD).

METHODS: We selected a subgroup from the Duke Established Populations for Epidemiologic Studies of the Elderly, a longitudinal study of community-representative persons aged 65-105 years living in 5 adjacent counties in North Carolina, and followed them for dementia (1986-1987 through June 2000). Information gathered during in-home interviews included sociodemographic characteristics, health status, health service use, and vitamin use. Diagnosis of dementia and AD was based on evaluations using the clinical and neuropsychological batteries of the Consortium to Establish a Registry for Alzheimer's Disease, with final determination by consensus agreement of specialists using Diagnostic and Statistical Manual of Mental Disorders, third revision, and National Institute for Neurological and Communicative Disorders and Stroke-Alzheimer's Disease and Related Disorders criteria.

RESULTS: Of 616 persons initially dementia-free (mean age 73 y; 62% female; 62% African American), 141 developed dementia, of whom 93 developed AD. Increased age and mobility problems were risk factors for dementia (only age for AD), while an increased number of outpatient visits reduced the likelihood of developing dementia. Neither use of any vitamins C and/or E (used by 8% of subjects at baseline) nor high-dose use reduced the time to dementia or AD.

CONCLUSIONS: In this community in the southeastern US where vitamin supplement use is low, use of vitamins C and/or E did not delay the incidence of dementia or AD.

Key Words: Alzheimer's disease, antioxidant, dementia, vitamin C, vitamin E

Published Online, October 14, 2005. www.theannals.com, DOI 10.1345/aph.1G280





homecopy help contact us subscription past issues search current issue
Copyright © 2005 by Harvey Whitney Books Company.